Standout Papers

Liver cirrhosis 1995 2026 2005 2015 1.3k
  1. Liver cirrhosis (2014)
    Emmanuel Tsochatzis, Jaime Bosch et al. The Lancet
  2. Portal hypertensive bleeding in cirrhosis (2016)
    Guadalupe García–Tsao, Juan G. Abraldeṣ et al. Hepatology
  3. Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis (2007)
    Cristina Ripoll, Roberto J. Groszmann et al. Gastroenterology
  4. The treatment of portal hypertension: A meta-analytic review (1995)
    Gennaro D’Amico, Luigi Pagliaro et al. Hepatology
  5. Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding (2010)
    Juan Carlos García‐Pagán, Karel Caca et al. New England Journal of Medicine
  6. Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis (2005)
    Roberto J. Groszmann, Guadalupe García–Tsao et al. New England Journal of Medicine
  7. Management of Varices and Variceal Hemorrhage in Cirrhosis (2010)
    Guadalupe García–Tsao, Jaime Bosch New England Journal of Medicine
  8. Pharmacological Treatment of Portal Hypertension: An Evidence-Based Approach (1999)
    Gennaro D’Amico, Luigi Pagliaro et al. Seminars in Liver Disease
  9. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial (2019)
    Càndid Villanueva, Agustı́n Albillos et al. The Lancet
  10. Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis (2012)
    Annalisa Berzigotti, Susana Seijó et al. Gastroenterology
  11. The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials (2019)
    Arun J. Sanyal, Stephen A. Harrison et al. Hepatology
  12. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction (2021)
    Cornelius Engelmann, Joan Clària et al. Journal of Hepatology
  13. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis (2023)
    David E. Kaplan, Cristina Ripoll et al. Hepatology
  14. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis (2022)
    Càndid Villanueva, Ferràn Torres et al. Journal of Hepatology

Immediate Impact

8 from Science/Nature 121 standout
Sub-graph 1 of 16

Citing Papers

Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
2025 Standout
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
2024 Standout
28 intermediate papers

Works of Jaime Bosch being referenced

The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options
2018
Hepatic Expression of CXC Chemokines Predicts Portal Hypertension and Survival in Patients With Alcoholic Hepatitis
2009
and 21 more

Author Peers

Author Last Decade Papers Cites
Jaime Bosch 26594 24267 13341 356 31.6k
Juan Carlos García‐Pagán 24888 22406 13217 449 29.7k
Patrick S. Kamath 22808 21671 12874 419 32.8k
Joan Rodés 22903 17464 10252 339 28.9k
Juan G. Abraldeṣ 13803 13375 6806 273 17.0k
Didier Lebrec 13243 10681 7136 405 17.9k
Don C. Rockey 8609 8056 5812 453 19.4k
Keith D. Lindor 22219 24788 13948 431 35.9k
Russell H. Wiesner 23550 17610 15852 322 32.1k
Pere Ginès 31358 26309 14969 450 37.9k
Juan Rodés 16270 13578 6781 185 19.5k

All Works

Loading papers...

Rankless by CCL
2026